查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1075525

藥物·設備組合產品的全球市場 (2021年～2028年):產業分析·規模·佔有率·成長·趨勢·預測

Drug-device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
出版日期: | 出版商: Transparency Market Research | 英文 117 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球藥物·設備組合產品的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·各地區/主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 序文

第2章 假設·調查手法

第3章 摘要整理:全球藥物·設備組合產品市場

第4章 市場概要

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球市場的分析·預測

第5章 重要洞察

  • 主要的收購與合併
  • 技術的進步
  • COVID-19:影響分析
  • 法規方案:世界·各地區

第6章 全球藥物·設備組合產品市場分析·預測:各產品類型

  • 簡介·定義
  • 主要調查結果·展開
  • 市場規模的預測
    • 藥物釋放型性支架
    • 輸液幫浦
    • 吸入器
    • 整形外科組合產品
    • 創傷護理組合產品
    • 光敏化劑
    • 其他
  • 市場魅力

第7章 全球藥物·設備組合產品市場分析·預測:各地區

  • 主要調查結果
  • 市場規模的預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力

第8章 北美的藥物·設備組合產品市場分析·預測

第9章 歐洲的藥物·設備組合產品市場分析·預測

第10章 亞太地區的藥物·設備組合產品市場分析·預測

第11章 南美的藥物·設備組合產品市場分析·預測

第12章 中東及非洲的藥物·設備組合產品市場分析·預測

第13章 競爭情形

  • 進入經營者:競爭矩陣(各企業等級·規模)
  • 市場佔有率分析:各企業
  • 企業簡介
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie, Inc.
    • Abbott Laboratories
    • Medtronic plc
    • Kaleo, Inc.
    • SINOMED
    • Alcon, Inc.
    • Boston Scientific Corporation
    • Integer Holdings Corporation
    • Teleflex Incorporated
    • Bausch Health Companies Inc
    • Haselmeier GmbH
Product Code: TMRGL1534

Drug-device Combination Products Market - Scope of Report

TMR's report on the global drug-device combination products market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global drug-device combination products market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug-device combination products market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global drug-device combination products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global drug-device combination products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global drug-device combination products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global drug-device combination products market.

The report delves into the competitive landscape of the global drug-device combination products market. Key players operating in the global drug-device combination products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global drug-device combination products market that have been profiled in this report.

Key Questions Answered in Drug-device Combination Products Market Report

What is the scope of growth of product companies in the global drug-device combination products market?

What will be the Y-o-Y growth of the global drug-device combination products market between 2017 and 2028?

What is the influence of changing trends in technologies on the global drug-device combination products market?

Will North America be the most profitable market for drug-device combination products providers?

Which factors are anticipated to hamper the growth of the global drug-device combination products market during the forecast period?

Which are the leading companies in the global drug-device combination products market?

Research Methodology

TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global drug-device combination products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global drug-device combination products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the drug-device combination products market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the drug-device combination products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global drug-device combination products market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global drug-device combination products market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug-device Combination Products Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug-device Combination Products Market Analysis and Forecast, 2017-2028

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Technological Advancements
  • 5.3. Covid19 Impact Analysis
  • 5.4. Regulatory Scenario by Region/globally

6. Global Drug-device Combination Products Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2028
    • 6.3.1. Drug Eluting Stents
      • 6.3.1.1. Coronary Stents
      • 6.3.1.2. Peripheral Vascular Stents
    • 6.3.2. Infusion Pumps
      • 6.3.2.1. Implantable Infusion Pumps
      • 6.3.2.2. Ambulatory Infusion Pumps
    • 6.3.3. Inhalers
      • 6.3.3.1. Metered Dose Inhalers
      • 6.3.3.2. Dry Powder Inhalers
      • 6.3.3.3. Nebulizers
    • 6.3.4. Orthopedic Combination Products
      • 6.3.4.1. Bone Graft Implants
      • 6.3.4.2. Antibiotic Loaded Bone Cement
    • 6.3.5. Wound Care Combination Products
    • 6.3.6. Photosensitizers
    • 6.3.7. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Drug-device Combination Products Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness Analysis, by Region

8. North America Drug-device Combination Products Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by Product Type, 2017-2027
    • 8.2.1. Drug Eluting Stents
      • 8.2.1.1. Coronary Stents
      • 8.2.1.2. Peripheral Vascular Stents
    • 8.2.2. Infusion Pumps
      • 8.2.2.1. Implantable Infusion Pumps
      • 8.2.2.2. Ambulatory Infusion Pumps
    • 8.2.3. Inhalers
      • 8.2.3.1. Metered Dose Inhalers
      • 8.2.3.2. Dry Powder Inhalers
      • 8.2.3.3. Nebulizers
    • 8.2.4. Orthopedic Combination Products
      • 8.2.4.1. Bone Graft Implants
      • 8.2.4.2. Antibiotic Loaded Bone Cement
    • 8.2.5. Wound Care Combination Products
    • 8.2.6. Photosensitizers
    • 8.2.7. Others
  • 8.3. Market Value Forecast by Country, 2017-2027
    • 8.3.1. U.S.
    • 8.3.2. Canada
  • 8.4. Market Attractiveness Analysis
    • 8.4.1. By Product Type
    • 8.4.2. By Country

9. Europe Drug-device Combination Products Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product Type, 2017-2027
    • 9.2.1. Drug Eluting Stents
      • 9.2.1.1. Coronary Stents
      • 9.2.1.2. Peripheral Vascular Stents
    • 9.2.2. Infusion Pumps
      • 9.2.2.1. Implantable Infusion Pumps
      • 9.2.2.2. Ambulatory Infusion Pumps
    • 9.2.3. Inhalers
      • 9.2.3.1. Metered Dose Inhalers
      • 9.2.3.2. Dry Powder Inhalers
      • 9.2.3.3. Nebulizers
    • 9.2.4. Orthopedic Combination Products
      • 9.2.4.1. Bone Graft Implants
      • 9.2.4.2. Antibiotic Loaded Bone Cement
    • 9.2.5. Wound Care Combination Products
    • 9.2.6. Photosensitizers
    • 9.2.7. Others
  • 9.3. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Market Attractiveness Analysis
    • 9.4.1. By Product Type
    • 9.4.2. By Country

10. Asia Pacific Drug-device Combination Products Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2027
    • 10.2.1. Drug Eluting Stents
      • 10.2.1.1. Coronary Stents
      • 10.2.1.2. Peripheral Vascular Stents
    • 10.2.2. Infusion Pumps
      • 10.2.2.1. Implantable Infusion Pumps
      • 10.2.2.2. Ambulatory Infusion Pumps
    • 10.2.3. Inhalers
      • 10.2.3.1. Metered Dose Inhalers
      • 10.2.3.2. Dry Powder Inhalers
      • 10.2.3.3. Nebulizers
    • 10.2.4. Orthopedic Combination Products
      • 10.2.4.1. Bone Graft Implants
      • 10.2.4.2. Antibiotic Loaded Bone Cement
    • 10.2.5. Wound Care Combination Products
    • 10.2.6. Photosensitizers
    • 10.2.7. Others
  • 10.3. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 10.3.1. Japan
    • 10.3.2. China
    • 10.3.3. India
    • 10.3.4. Australia & New Zealand
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Product Type
    • 10.4.2. By Country

11. Latin America Drug-device Combination Products Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2027
    • 11.2.1. Drug Eluting Stents
      • 11.2.1.1. Coronary Stents
      • 11.2.1.2. Peripheral Vascular Stents
    • 11.2.2. Infusion Pumps
      • 11.2.2.1. Implantable Infusion Pumps
      • 11.2.2.2. Ambulatory Infusion Pumps
    • 11.2.3. Inhalers
      • 11.2.3.1. Metered Dose Inhalers
      • 11.2.3.2. Dry Powder Inhalers
      • 11.2.3.3. Nebulizers
    • 11.2.4. Orthopedic Combination Products
      • 11.2.4.1. Bone Graft Implants
      • 11.2.4.2. Antibiotic Loaded Bone Cement
    • 11.2.5. Wound Care Combination Products
    • 11.2.6. Photosensitizers
    • 11.2.7. Others
  • 11.3. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Product Type
    • 11.4.2. By Country

12. Middle East & Africa Drug-device Combination Products Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast by Product Type, 2017-2027
    • 12.2.1. Drug Eluting Stents
      • 12.2.1.1. Coronary Stents
      • 12.2.1.2. Peripheral Vascular Stents
    • 12.2.2. Infusion Pumps
      • 12.2.2.1. Implantable Infusion Pumps
      • 12.2.2.2. Ambulatory Infusion Pumps
    • 12.2.3. Inhalers
      • 12.2.3.1. Metered Dose Inhalers
      • 12.2.3.2. Dry Powder Inhalers
      • 12.2.3.3. Nebulizers
    • 12.2.4. Orthopedic Combination Products
      • 12.2.4.1. Bone Graft Implants
      • 12.2.4.2. Antibiotic Loaded Bone Cement
    • 12.2.5. Wound Care Combination Products
    • 12.2.6. Photosensitizers
    • 12.2.7. Others
  • 12.3. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Rest of Middle East & Africa
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Product Type
    • 12.4.2. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (by tier and size of companies)
  • 13.2. Market Share Analysis, by Company, 2020
  • 13.3. Company Profiles
    • 13.3.1. Teva Pharmaceutical Industries Ltd.
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Financial Analysis
      • 13.3.1.3. Growth Strategies
      • 13.3.1.4. SWOT Analysis
    • 13.3.2. AbbVie, Inc.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Financial Analysis
      • 13.3.2.3. Growth Strategies
      • 13.3.2.4. SWOT Analysis
    • 13.3.3. Abbott Laboratories
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Financial Analysis
      • 13.3.3.3. Growth Strategies
      • 13.3.3.4. SWOT Analysis
    • 13.3.4. Medtronic plc
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Financial Analysis
      • 13.3.4.3. Growth Strategies
      • 13.3.4.4. SWOT Analysis
    • 13.3.5. Kaleo, Inc.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Financial Analysis
      • 13.3.5.3. Growth Strategies
      • 13.3.5.4. SWOT Analysis
    • 13.3.6. SINOMED
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Financial Analysis
      • 13.3.6.3. Growth Strategies
      • 13.3.6.4. SWOT Analysis
    • 13.3.7. Alcon, Inc.
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Financial Analysis
      • 13.3.7.3. Growth Strategies
      • 13.3.7.4. SWOT Analysis
    • 13.3.8. Boston Scientific Corporation
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Financial Analysis
      • 13.3.8.3. Growth Strategies
      • 13.3.8.4. SWOT Analysis
    • 13.3.9. Integer Holdings Corporation
      • 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.9.2. Financial Analysis
      • 13.3.9.3. Growth Strategies
      • 13.3.9.4. SWOT Analysis
    • 13.3.10. Teleflex Incorporated
      • 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.10.2. Financial Analysis
      • 13.3.10.3. Growth Strategies
      • 13.3.10.4. SWOT Analysis
    • 13.3.11. Bausch Health Companies Inc
      • 13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.11.2. Financial Analysis
      • 13.3.11.3. Growth Strategies
      • 13.3.11.4. SWOT Analysis
    • 13.3.12. Haselmeier GmbH
      • 13.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.12.2. Financial Analysis
      • 13.3.12.3. Growth Strategies
      • 13.3.12.4. SWOT Analysis

List of Tables

  • Table 01: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
  • Table 02: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 03: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 04: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
  • Table 05: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 06: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
  • Table 07: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 08: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
  • Table 09: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 10: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
  • Table 11: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 12: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

List of Figures

  • Figure 01: Global Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
  • Figure 02: Global Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
  • Figure 03: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 04: North America Drug-device Combination Products Market Value Share Analysis, by Country, 2021 and 2027
  • Figure 05: North America Drug-device Combination Products Market Attractiveness Analysis, by Country, 2021-2027
  • Figure 06: North America Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
  • Figure 07: North America Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
  • Figure 08: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 09: Europe Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
  • Figure 10: Europe Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
  • Figure 11: Europe Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
  • Figure 12: Europe Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
  • Figure 13: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 14: Asia Pacific Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
  • Figure 15: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
  • Figure 16: Asia Pacific Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
  • Figure 17: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
  • Figure 18: Latin America Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
  • Figure 19: Latin America Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
  • Figure 20: Latin America Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
  • Figure 21: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
  • Figure 22: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
  • Figure 23: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, by Product, 2021-2027